Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.Jesús Troya,Pablo Ryan,Esteban Ribera,Daniel Podzamczer,Victor Hontañón,Jose Alberto Terrón,Vicente Boix,Santiago Moreno,Pilar Barrufet,Manuel Castaño,Ana Carrero,María José Galindo,Ignacio Suárez-Lozano,Hernando Knobel,Miguel Raffo,Javier Solís,María Yllescas,Herminia Esteban,Juan González-García,Juan Berenguer,Arkaitz ImazPLOS ONE（2017）引用 6|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
